These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26813954)

  • 41. VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1.
    Labrousse-Arias D; Martínez-Alonso E; Corral-Escariz M; Bienes-Martínez R; Berridy J; Serrano-Oviedo L; Conde E; García-Bermejo ML; Giménez-Bachs JM; Salinas-Sánchez AS; Sánchez-Prieto R; Yao M; Lasa M; Calzada MJ
    J Cell Biol; 2017 Mar; 216(3):835-847. PubMed ID: 28235946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptomics in RCC.
    Syed JS; Brito J; Pooli A; Boutros PC; Shuch B
    Urol Oncol; 2020 Oct; 38(10):742-754. PubMed ID: 32222350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kidney cancer: Programmed death ligand 1 regulation in ccRCC.
    Stone L
    Nat Rev Urol; 2016 Feb; 13(2):65. PubMed ID: 26754191
    [No Abstract]   [Full Text] [Related]  

  • 44. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype.
    Papadopoulos EI; Petraki C; Gregorakis A; Fragoulis EG; Scorilas A
    Biol Chem; 2016 Jun; 397(6):529-39. PubMed ID: 26866880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Molecular Profiling in Diagnosis of Papillary Renal-cell Cancer Presenting as Cancer of Unknown Primary Site.
    Nagasaka M; Kukreja G; Abdulfatah E; Vaishampayan U; Sukari A
    Clin Genitourin Cancer; 2017 Aug; 15(4):e713-e717. PubMed ID: 28024951
    [No Abstract]   [Full Text] [Related]  

  • 47. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.
    Ge YZ; Wu R; Xin H; Zhu M; Lu TZ; Liu H; Xu Z; Yu P; Zhao YC; Li MH; Hu ZK; Zhao Y; Zhong B; Xu X; Zhou LH; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1291-9. PubMed ID: 25633718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
    Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of Translationally Controlled Tumor Protein in Human Kidney and in Renal Cell Carcinoma.
    Ambrosio MR; Rocca BJ; Barone A; Onorati M; Mundo L; Crivelli F; Di Nuovo F; De Falco G; del Vecchio MT; Tripodi SA; Tosi P
    Biomed Res Int; 2015; 2015():730390. PubMed ID: 26425551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
    Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
    Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 55. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
    Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA
    Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.
    Tan X; Zhai Y; Chang W; Hou J; He S; Lin L; Yu Y; Xu D; Xiao J; Ma L; Wang G; Cao T; Cao G
    Int J Cancer; 2008 Sep; 123(5):1080-8. PubMed ID: 18546293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
    Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
    J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The molecular biology of renal cancer: another piece of the puzzle.
    Stewart GD; Harrison DJ; Berney DM; Powles T
    Eur Urol; 2014 Jul; 66(1):85-6. PubMed ID: 24674147
    [No Abstract]   [Full Text] [Related]  

  • 60. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.